Research Article
Rutin Protects against Pirarubicin-Induced Cardiotoxicity through TGF-β1-p38 MAPK Signaling Pathway
Figure 2
Posttreatment cell viability assessment on MTT assay. versus control; versus THP; versus DZR + THP. versus RUT (50 μM) + THP; versus SB203580 + THP; versus RUT + SB203580 + THP. DZR, dexrazoxane; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; THP, pirarubicin.